These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29554483)

  • 1. Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy.
    Deng R; Shen N; Yang Y; Yu H; Xu S; Yang YW; Liu S; Meguellati K; Yan F
    Biomaterials; 2018 Jun; 167():80-90. PubMed ID: 29554483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis.
    Shen N; Yan F; Pang J; Wu LC; Al-Kali A; Litzow MR; Liu S
    Oncotarget; 2014 Jul; 5(14):5494-509. PubMed ID: 25015109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer.
    Kardani A; Yaghoobi H; Alibakhshi A; Khatami M
    J Cell Physiol; 2020 Oct; 235(10):6887-6895. PubMed ID: 32003016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional Gold Nanoparticles Overcome MicroRNA Regulatory Network Mediated-Multidrug Resistant Leukemia.
    Deng R; Ji B; Yu H; Bao W; Yang Z; Yu Y; Cui Y; Du Y; Song M; Liu S; Meguellati K; Yan F
    Sci Rep; 2019 Mar; 9(1):5348. PubMed ID: 30926883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.
    Huang X; Schwind S; Santhanam R; Eisfeld AK; Chiang CL; Lankenau M; Yu B; Hoellerbauer P; Jin Y; Tarighat SS; Khalife J; Walker A; Perrotti D; Bloomfield CD; Wang H; Lee RJ; Lee LJ; Marcucci G
    Oncotarget; 2016 Sep; 7(37):59273-59286. PubMed ID: 27517749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
    Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
    Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary study on the role of miR‑148a and DNMT1 in the pathogenesis of acute myeloid leukemia.
    Wang XX; Zhang H; Li Y
    Mol Med Rep; 2019 Apr; 19(4):2943-2952. PubMed ID: 30720097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DNA methylation-mediated epigenetic silencing of miR-720 contributes to leukemogenesis in acute myeloid leukemia].
    Tang S; Pei R; Li K; Ma J; Zhang P; Lu Y; Liu X; DU X; Chen D; Sha K; Cao J; Li S
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):1009-12. PubMed ID: 25417880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
    Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
    Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target.
    Yan F; Shen N; Pang JX; Zhao N; Zhang YW; Bode AM; Al-Kali A; Litzow MR; Li B; Liu SJ
    Leukemia; 2018 Apr; 32(4):865-873. PubMed ID: 28993705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia.
    Dorrance AM; Neviani P; Ferenchak GJ; Huang X; Nicolet D; Maharry KS; Ozer HG; Hoellarbauer P; Khalife J; Hill EB; Yadav M; Bolon BN; Lee RJ; Lee LJ; Croce CM; Garzon R; Caligiuri MA; Bloomfield CD; Marcucci G
    Leukemia; 2015 Nov; 29(11):2143-53. PubMed ID: 26055302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL-AuNPs-BMS Nanoparticle Conjugates as Molecularly Targeted Therapy for Leukemia.
    Shen N; Yan F; Pang J; Gao Z; Al-Kali A; Haynes CL; Litzow MR; Liu S
    ACS Appl Mater Interfaces; 2018 May; 10(17):14454-14462. PubMed ID: 29668254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathological role and prognostic impact of miR-181 in acute myeloid leukemia.
    Weng H; Lal K; Yang FF; Chen J
    Cancer Genet; 2015 May; 208(5):225-9. PubMed ID: 25686674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia.
    Shen N; Yan F; Pang J; Zhao N; Gangat N; Wu L; Bode AM; Al-Kali A; Litzow MR; Liu S
    Clin Cancer Res; 2017 Oct; 23(20):6254-6266. PubMed ID: 28720666
    [No Abstract]   [Full Text] [Related]  

  • 16. A minicircuitry comprised of microRNA-9 and SIRT1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
    Zhou L; Fu L; Lv N; Chen XS; Liu J; Li Y; Xu QY; Huang S; Zhang XD; Dou LP; Wang LL; Li YH; Yu L
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):786-794. PubMed ID: 28272704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.
    Tagde A; Rajabi H; Stroopinsky D; Gali R; Alam M; Bouillez A; Kharbanda S; Stone R; Avigan D; Kufe D
    Oncotarget; 2016 Jun; 7(26):38974-38987. PubMed ID: 27259275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
    De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
    Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
    Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
    BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles.
    Jiang X; Bugno J; Hu C; Yang Y; Herold T; Qi J; Chen P; Gurbuxani S; Arnovitz S; Strong J; Ferchen K; Ulrich B; Weng H; Wang Y; Huang H; Li S; Neilly MB; Larson RA; Le Beau MM; Bohlander SK; Jin J; Li Z; Bradner JE; Hong S; Chen J
    Cancer Res; 2016 Aug; 76(15):4470-80. PubMed ID: 27280396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.